闪退
闪退闪退闪退
健享互联
Published by:
Shenzhen Nanshan Center For Chronic Disease Control
Description
《健享互联》是一款实现结核病“vDOT”督导管理为主的应用程序。结核病是慢性传染性疾病，具备病程长，需要全程规律服药和定期复查的特点。该应用程序以高效化、智能化、人性化模式实现DOTs管理，可减少患者每天去医疗机构取药的成本、确保患者规律治疗和提高医务人员工作效率。患者用户可实现服药提醒、复查提醒、上报不良反应、健康知识学习和在线医患沟通等。医务人员用户可通过该应用程序开展确认患者服药、及时处理患者不良反应、掌上查看患者复查情况、药品管理、健康服务规范管理和在线医患沟通等工作。目前该应用程序已经在深圳、江西、新疆和广西等省市得到了推广应用。
Screenshots
健享互联 FAQ
-
Is 健享互联 free?
Yes, 健享互联 is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is 健享互联 legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does 健享互联 cost?
健享互联 is free.
-
What is 健享互联 revenue?
To get estimated revenue of 健享互联 app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Türkiye yet.
Ratings History
健享互联 Reviews
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet
健享互联 Installs
Last 30 days
健享互联 Revenue
Last 30 days健享互联 Revenue and Downloads
Gain valuable insights into 健享互联 performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Lifestyle
- Languages
- English, Chinese
- Recent release
- 4.0.1 (1 month ago )
- Released on
- Apr 26, 2017 (7 years ago )
- Also available in
- China , Japan , Vietnam , United States , Ukraine , Taiwan , Türkiye , Thailand , Sweden , Saudi Arabia , Peru , Netherlands , South Korea , United Arab Emirates , Italy , India , Hong Kong SAR China , France , Spain , Egypt , Czechia , Colombia , Chile , Australia
- Last Updated
- 4 weeks ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.